• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sanofi - American Depositary Shares (NQ:SNY)

    49.90 -2.23 (-4.28%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,156,987
    Open 50.29
    Bid (Size) 49.90 (1)
    Ask (Size) 50.10 (2)
    Prev. Close 52.13
    Today's Range 49.88 - 50.60
    52wk Range 45.80 - 60.12
    Shares Outstanding 1,250,690,553
    Dividend Yield 4.08%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why
    Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year outlook raised above expectations. 
    Via Benzinga
    Exposures COVID-19
    AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma
    AstraZeneca's Breztri met primary goals in four asthma trials, including KALOS, LOGOS, LITHOS, and VATHOS, involving over 5,000 patients. 
    Via Benzinga

    Performance

    YTD
    +3.5%
    +3.5%
    1 Month
    -2.6%
    -2.6%
    3 Month
    -6.5%
    -6.5%
    6 Month
    -2.8%
    -2.8%
    1 Year
    +2.5%
    +2.5%

    More News

    Read More
    SANOFI-ADR (NASDAQ:SNY): A Strong Growth Stock with Technical Breakout Potential
    Via Chartmill
    French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit
    Via Benzinga
    Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed
    Via Investor's Business Daily
    Topics Earnings Government
    Exposures Financial Political
    Earnings Scheduled For April 24, 2025
    Via Benzinga
    Why SANOFI-ADR (NASDAQ:SNY) provides a good dividend, while having solid fundamentals.
    Via Chartmill
    Regeneron Expands US Manufacturing With $3 Billion Fujifilm Deal
    Via Benzinga
    Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
    From Regeneron Pharmaceuticals, Inc.
    Via GlobeNewswire
    Sanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study
    Via Benzinga
    How Do Investors Really Feel About Sanofi?
    Via Benzinga
    Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
    Via Benzinga
    Topics Government Supply Chain World Trade
    Exposures Political Supply Chain Tariff
    Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
    Via Investor's Business Daily
    Topics Government Stocks World Trade
    Exposures Political Tariff US Equities
    All the Stocks Warren Buffett Bought in the Last 2 Recessions: Are They Smart Picks Now?
    Via The Motley Fool
    Topics Economy Government World Trade
    Exposures COVID-19 Economy Political
    Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst
    Via Benzinga
    Topics World Trade
    Exposures Product Safety Tariff
    Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?
    Via Benzinga
    Exposures Product Safety
    Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
    Via Investor's Business Daily
    FDA Approves Sanofi's Hemophilia Drug
    Via Benzinga
    Exposures Product Safety
    Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
    From Regeneron Pharmaceuticals, Inc.
    Via GlobeNewswire
    Don't overlook SANOFI-ADR (NASDAQ:SNY)—it's a hidden gem with strong fundamentals and an attractive price tag.
    Via Chartmill
    Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
    Via Benzinga
    This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
    Via Benzinga
    Sanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal
    Via Benzinga
    Exploring SANOFI-ADR (NASDAQ:SNY)'s dividend characteristics.
    Via Chartmill

    Frequently Asked Questions

    Is Sanofi - American Depositary Shares publicly traded?
    Yes, Sanofi - American Depositary Shares is publicly traded.
    What exchange does Sanofi - American Depositary Shares trade on?
    Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Sanofi - American Depositary Shares?
    The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
    What is the current price of Sanofi - American Depositary Shares?
    The current price of Sanofi - American Depositary Shares is 49.90
    When was Sanofi - American Depositary Shares last traded?
    The last trade of Sanofi - American Depositary Shares was at 05/09/25 04:00 PM ET
    What is the market capitalization of Sanofi - American Depositary Shares?
    The market capitalization of Sanofi - American Depositary Shares is 62.41B
    How many shares of Sanofi - American Depositary Shares are outstanding?
    Sanofi - American Depositary Shares has 62B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.